Skip to main content

Peer Review reports

From: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

Original Submission
25 Nov 2008 Submitted Original manuscript
10 Mar 2009 Author responded Author comments - Haleema Shakur
Resubmission - Version 2
10 Mar 2009 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
17 Apr 2009 Reviewed Reviewer Report - Livia Candelise
15 Jun 2009 Author responded Author comments - Haleema Shakur
Resubmission - Version 4
15 Jun 2009 Submitted Manuscript version 4
Publishing
3 Dec 2009 Editorially accepted
3 Dec 2009 Article published 10.1186/1745-6215-10-109

You can find further information about peer review here.

Back to article page